These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28541593)

  • 1. Clinical and prognostic relevancy of left ventricular trabeculation assessed by cardiac magnetic resonance in patients with dilated cardiomyopathy.
    Mazurkiewicz Ł; Petryka J; Śpiewak M; Miłosz-Wieczorek B; Małek ŁA; Jasińska A; Jarmus E; Marczak M; Misko J; Grzybowski J
    Kardiol Pol; 2017; 75(8):794-803. PubMed ID: 28541593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Impact of Hypertrabeculation and Noncompaction Phenotype in Dilated Cardiomyopathy: A CMR Study.
    Amzulescu MS; Rousseau MF; Ahn SA; Boileau L; de Meester de Ravenstein C; Vancraeynest D; Pasquet A; Vanoverschelde JL; Pouleur AC; Gerber BL
    JACC Cardiovasc Imaging; 2015 Aug; 8(8):934-46. PubMed ID: 26189121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between left ventricular sphericity and trabeculation indexes in patients with dilated cardiomyopathy: a cardiac magnetic resonance study.
    Marchal P; Lairez O; Cognet T; Chabbert V; Barrier P; Berry M; Méjean S; Roncalli J; Rousseau H; Carrié D; Galinier M
    Eur Heart J Cardiovasc Imaging; 2013 Sep; 14(9):914-20. PubMed ID: 23644933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal pro brain natriuretic peptide to predict prognosis in dilated cardiomyopathy with sinus rhythm.
    Tigen K; Karaahmet T; Kahveci G; Tanalp AC; Bitigen A; Fotbolcu H; Bayrak F; Mutlu B; Basaran Y
    Heart Lung Circ; 2007 Aug; 16(4):290-4. PubMed ID: 17403613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between Myocardial Extracellular Space Expansion Estimated with Post-Contrast T1 Mapping MRI and Left Ventricular Remodeling and Neurohormonal Activation in Patients with Dilated Cardiomyopathy.
    Yoon JH; Son JW; Chung H; Park CH; Kim YJ; Chang HJ; Hong GR; Kim TH; Ha JW; Choi BW; Rim SJ; Chung N; Choi EY
    Korean J Radiol; 2015; 16(5):1153-62. PubMed ID: 26355278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome and prognostic value of N-terminal pro-brain natriuretic peptide and high-sensitivity C-reactive protein in mildly dilated cardiomyopathy vs. dilated cardiomyopathy.
    Feng J; Tian P; Liang L; Chen Y; Wang Y; Zhai M; Huang Y; Zhou Q; Zhao X; Zhao L; Huang B; Huang L; Zhang Y; Zhang J
    ESC Heart Fail; 2022 Jun; 9(3):1625-1635. PubMed ID: 35243815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic utility of anemia and pro-B-type natriuretic peptide in patients with nonischemic dilated cardiomyopathy and normal renal function.
    Tigen K; Karaahmet T; Cevik C; Gurel E; Mutlu B; Basaran Y
    Am J Med Sci; 2009 Feb; 337(2):109-15. PubMed ID: 19214026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of N-terminal pro-brain natriuretic Peptide in outpatients with hypertrophic cardiomyopathy.
    D'Amato R; Tomberli B; Castelli G; Spoladore R; Girolami F; Fornaro A; Caldini A; Torricelli F; Camici P; Gensini GF; Cecchi F; Olivotto I
    Am J Cardiol; 2013 Oct; 112(8):1190-6. PubMed ID: 23871673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up.
    Vrtovec B; Poglajen G; Lezaic L; Sever M; Domanovic D; Cernelc P; Socan A; Schrepfer S; Torre-Amione G; Haddad F; Wu JC
    Circ Res; 2013 Jan; 112(1):165-73. PubMed ID: 23065358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NT-proBNP as a marker for persistent cardiac disease in children with history of dilated cardiomyopathy and myocarditis.
    Nasser N; Perles Z; Rein AJJT; Nir A
    Pediatr Cardiol; 2006; 27(1):87-90. PubMed ID: 16132296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of clinical, electrocardiographic, echocardiographic and neurohumoral parameters in non-ischaemic dilated cardiomyopathy.
    Tigen K; Karaahmet T; Tanalp AC; Gurel E; Cevik C; Mutlu B; Basaran Y
    Acta Cardiol; 2008 Apr; 63(2):207-12. PubMed ID: 18468202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of plasma TSG-6 with cardiac function, myocardial fibrosis, and prognosis in dilated cardiomyopathy patients with heart failure.
    Xu L; Zhang Y; Kuang Y; Fang H; Ma Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 46(7):689-696. PubMed ID: 34382584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.
    Kremastinos DT; Hamodraka E; Parissis J; Tsiapras D; Dima K; Maisel A
    Am Heart J; 2010 Jan; 159(1):68-74. PubMed ID: 20102869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tenascin-C as predictor of left ventricular remodeling and mortality in patients with dilated cardiomyopathy.
    Sarli B; Topsakal R; Kaya EG; Akpek M; Lam YY; Kaya MG
    J Investig Med; 2013 Apr; 61(4):728-32. PubMed ID: 23429699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of Left Ventricular Functional Recovery and Their Impact on Clinical Outcomes in Patients With Newly Diagnosed Dilated Cardiomyopathy and Heart Failure.
    Cho JY; Kim KH; Song JE; Kim JE; Park H; Yoon HJ; Yoon NS; Hong YJ; Park HW; Kim JH; Ahn Y; Jeong MH; Cho JG; Park JC
    Heart Lung Circ; 2018 Jan; 27(1):41-49. PubMed ID: 28420549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implications of the NT-ProBNP level and left atrial size in non-ischemic dilated cardiomyopathy.
    Kim H; Cho YK; Jun DH; Nam CW; Han SW; Hur SH; Kim YN; Kim KB
    Circ J; 2008 Oct; 72(10):1658-65. PubMed ID: 18728335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of trabeculated myocardium burden in young and apparently healthy adults.
    Tizón-Marcos H; de la Paz Ricapito M; Pibarot P; Bertrand O; Bibeau K; Le Ven F; Sinha S; Engert J; Bédard E; Pasian S; Deschepper C; Larose E
    Am J Cardiol; 2014 Oct; 114(7):1094-9. PubMed ID: 25132331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fat deposition in dilated cardiomyopathy assessed by CMR.
    Lu M; Zhao S; Jiang S; Yin G; Wang C; Zhang Y; Liu Q; Cheng H; Ma N; Zhao T; Chen X; Huang J; Zou Y; Song L; He Z; An J; Renate J; Xue H; Shah S
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):889-98. PubMed ID: 23850250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal proBNP levels in patients with Chagas disease: a marker of systolic and diastolic dysfunction of the left ventricle.
    Barbosa MM; Nunes Mdo C; Ribeiro AL; Barral MM; Rocha MO
    Eur J Echocardiogr; 2007 Jun; 8(3):204-12. PubMed ID: 16651029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma N-terminal protype-B natriuretic peptide levels in risk assessment of patients with mitral regurgitation secondary to ischemic and nonischemic dilated cardiomyopathy.
    Dini FL; Fontanive P; Conti U; Andreini D; Cabani E; De Tommasi SM
    Am Heart J; 2008 Jun; 155(6):1121-7. PubMed ID: 18513528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.